Comparative analysis on low- and standard-dose regimes of alteplase thrombolytic therapy for acute ischemic stroke: Efficacy and safety
European Neurology Dec 20, 2017
Zhao G, et al. - The efficacy and safety of low-dose and standard-dose alteplase intravenous thrombolytic therapy for acute ischemic stroke (AIS) were investigated in this study. For AIS, the efficacy of low-dose alteplase intravenous thrombolytic therapy was similar to the standard-dose regimen but with higher safety.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
